Clinical commissioning policy: Sirolimus in extracranial slow-flow vascular malformations refractory to standard therapies

Document first published:
Page updated:
Topic:
Publication type:

Sirolimus in extracranial slow-flow vascular malformations refractory to standard therapies (all ages) is recommended to be available as a routine commissioning policy within the criteria set out in this document.

Document

Clinical commissioning policy: sirolimus in extracranial slow-flow vascular malformations refractory to standard therapies

Clinical commissioning policy: sirolimus in extracranial slow-flow vascular malformations refractory to standard therapies

  • PDF
  • 236 KB
  • 10 pages

Summary

Published 16 July 2026.